Establishment and evaluation of a triple-color human papillomavirus pseudovirion neutralization assay

Objective: To establish a triple-color pseudovirion-based neutralization assay (PBNA) and evaluate its capability of detecting immunogenicity of the sera generated by the immunization of HPV 9-valent vaccine. Methods: HPV pseudovirus (PsVs) 6/11/16/18/31/33/45/52/58 with the encapsidated fluorescence expressing red fluorescent plasmid N31-MCHREEY, green fluorescent N31-EGFP or blue fluorescent N31-mTagBFP were generated. The concentration of HPV PsVs and the infection titers of HPV PsVs were detected by double-antibody sandwich ELISA and TCID(50), respectively. The single- and triple color HPV 16/33/45 PsVs were used to detect the neutralization titers of mice sera immunized with HPV 9-valent vaccine and confirmed the accuracy and specificity of the triple-color PBNAs. Then, the single- and triple color HPV 6/11/18/31/33/45/52/58 PsVs were employed to detect the neutralization titers of cynomolgus macaques sera immunized with HPV 9-valent vaccine and determined whether the triple-color PBNAs could be applied to evaluate the immunogenicity of the sera generated by the immunization of HPV9-valent vaccine. Results: The concentration of HPV16 PsVs encapsulating green, red or blue fluorescent plasmid was 5.0 to 6.0 μg/ml and HPV6/11/18/31/33/45/52/59 triple-color HPV PsVs was about 1.0 to 3.0 μg/ml. 9 types HPV PsVs containing EGFP, Mcherry or mTagBFP reporter plasmid were obtained and the concentration can meet the need of neutralization detection. 9 types single-color fluorescent HPV PsVs had similar infectivity against 293FT cells with the infection titer values between 1×10(4) and 1×10(5). The results of PBNAs showed that there was no significant difference in the anti-HPV neutralization titers of mice sera induced by HPV 9-valent vaccine between single-color and triple-color HPV16/33/45 PsVs (P>0.05). Similarly, there was also no significant difference in the anti-HPV neutralization titers of cynomolgus macaques sera induced by HPV 9-valent vaccine between single-color and triple-color HPV6/11/18/31/33/45/52/58 PsVs (P>0.05). Conclusion: We successfully established the triple-color PBNAs and verified the accuracy and specificity of triple-color PBNAs consistent with single-color PBNAs. The triple-color PBNAs can be applied to evaluate the immunogenicity of HPV 9-valent vaccine's immune serum.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:52

Enthalten in:

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine - 52(2018), 10 vom: 06. Okt., Seite 1039-1044

Sprache:

Chinesisch

Beteiligte Personen:

Wei, S P [VerfasserIn]
Fan, F [VerfasserIn]
Chen, J [VerfasserIn]
Liu, X L [VerfasserIn]
Yang, Y R [VerfasserIn]
Wang, Z P [VerfasserIn]
Song, S [VerfasserIn]
Li, Z H [VerfasserIn]
Wei, M X [VerfasserIn]
Wang, D N [VerfasserIn]
Li, S W [VerfasserIn]
Xia, N S [VerfasserIn]

Links:

Volltext

Themen:

Antibodies, Viral
HPV triple-color pseudovirus
Human papillomavirus
Immune sera
Journal Article
Neutralization tests
Papillomavirus Vaccines
Vaccine

Anmerkungen:

Date Completed 12.04.2019

Date Revised 12.04.2019

published: Print

Citation Status MEDLINE

doi:

10.3760/cma.j.issn.0253-9624.2018.10.014

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM290256410